Transfollicular delivery takes root: The future for vaccine design?

Expert Review of Vaccines

Volumn 13, Issue 1, 2014, Pages 5-7

  Hansen, Steffi ^a   Lehr, Claus Michael ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

adjuvant; antigen; immunization; microparticles; nanoparticles; transfollicular delivery

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIGEN; IMMUNOLOGICAL ADJUVANT; ISCOM; ISCOMATRIX; NANOCARRIER; NANOPARTICLE; UNCLASSIFIED DRUG; VACCINE; VIROSOME;

ANTIGEN PRESENTING CELL; BIODEGRADABILITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG PENETRATION; HAIR FOLLICLE; HUMAN; HYDROPHILICITY; IMMUNIZATION; LANGERHANS CELL; MICROEMULSION; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PERMEABILITY BARRIER; PRIORITY JOURNAL; REVIEW; STRATUM CORNEUM; VACCINATION;

ADMINISTRATION, CUTANEOUS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HAIR FOLLICLE; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; VACCINES;

EID: 84893118352     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.862500     Document Type: Review

References (15)

1. Glenn GM, Taylor DN, Li X, Frankel S, Montemarano A, Alving CR. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat. Med. 6(12), 1403-1406 (2000).
2. Mittal A, Raber AS, Schaefer UF et al. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization. Vaccine 31(34), 3442-3451 (2013).
3. Combadiere B, Vogt A, Mahe B et al. Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS ONE 5(5), e10818 (2010).
4. Baleeiro RB, Wiesmu?ller K-HH, Reiter Y et al. Topical vaccination with functionalized particles targeting dendritic cells. J. Invest. Dermatol. 133(8), 1933-1941 (2013).
5. Fan H, Lin Q, Morrissey GR, Khavari PA. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. 17(9), 870-872 (1999).
6. Meidan VM, Bonner MC, Michniak BB. Transfollicular drug delivery-is it a reality? Int. J. Pharm. 306(1-2), 1-14 (2005).
7. Gilliam AC, Kremer IB, Yoshida Y et al. The human hair follicle: a reservoir of CD40+ B7-deficient Langerhans cells that repopulate epidermis after UVB exposure. J. Invest. Dermatol. 110(4), 422-427 (1998).
8. Brandner JM, McIntyre M, Kief S, Wladykowski E, Moll I. Expression and localization of tight junction-associated proteins in human hair follicles. Arch. Dermatol. Res. 295(5), 211-221 (2003).
9. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J. Exp. Med. 206(13), 2937-2946 (2009).
10. Paus R, Ito N, Takigawa M, Ito T. The hair follicle and immune privilege. J. Investig. Dermatol. Symp. Proc. 8(2), 188-194 (2003).
11. Hofmann U, Tokura Y, Nishijima T, Takigawa M, Paus R. Hair cycle-dependent changes in skin immune functions: anagen-associated depression of sensitization for contact hypersensitivity in mice. J. Investig. Dermatol. 106(4), 598-604 (1996).
12. Mattheolabakis G, Lagoumintzis G, Panagi Z, Papadimitriou E, Partidos CD, Avgoustakis K. Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses. Int. J. Pharm. 385(1-2), 187-193 (2010).
13. Mittal A, Raber AS, Hansen S. Particle based vaccine formulations for transcutaneous immunization. Hum. Vaccin. Immunother. 9(9) (2013).
14. Lademann J, Richter H, Teichmann A et al. Nanoparticles -an efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 66(2), 159-164 (2007).
15. Patzelt A, Richter H, Knorr F et al. Selective follicular targeting by modification of the particle sizes. J. Control Release 150(1), 45-48 (2011).